Which Hepatitis C Drugs Interact with Lipitor?
Lipitor (atorvastatin), a statin used to lower cholesterol, is primarily metabolized by the CYP3A4 enzyme in the liver. Several direct-acting antiviral (DAA) regimens for hepatitis C inhibit or induce this enzyme, raising atorvastatin blood levels and increasing risks of muscle damage (myopathy or rhabdomyolysis), liver toxicity, or kidney issues. Co-administration often requires dose adjustments, monitoring, or switching statins.[1]
Key interacting Hep C meds include:
- Glecaprevir/pibrentasvir (Mavyret): Strong CYP3A4 inhibitor. Avoid atorvastatin or limit to 20 mg daily max.[1][2]
- Sofosbuvir/velpatasvir (Epclusa): Moderate CYP3A4 inhibitor via velpatasvir. Limit atorvastatin to 20 mg daily.[1]
- Grazoprevir/elbasvir (Zepatier): Strong CYP3A4 inhibitor. Avoid atorvastatin entirely.[1][2]
- Sofosbuvir/velpatasvir/voxilaprevir (Vosevi): Strong CYP3A4 inhibitor. Avoid atorvastatin.[1]
- Ledipasvir/sofosbuvir (Harvoni): Moderate CYP3A4 inhibitor. Limit atorvastatin to 20 mg daily.[1]
Non-interacting or low-risk options:
- Sofosbuvir alone or with daclatasvir/ribavirin typically has minimal impact on atorvastatin.[1]
What Happens in These Interactions?
Elevated atorvastatin levels amplify side effects like muscle pain, weakness, or elevated creatine kinase (CK) levels. Severe cases lead to rhabdomyolysis, which can cause kidney failure. Symptoms often appear within weeks; monitor CK, liver enzymes, and symptoms closely.[1][3]
How Should Doctors Manage This?
- Reduce atorvastatin dose (e.g., to 10-20 mg) or switch to pravastatin or rosuvastatin, which rely less on CYP3A4.[1][2]
- Time doses apart if possible, though not always effective.
- Baseline and periodic labs (CK, ALT/AST, creatinine) recommended.
- Consult a pharmacist or use tools like the Liverpool HEP Drug Interactions checker for patient-specific advice.[3]
Why Do These Interactions Occur?
Hep C DAAs target viral proteins but also affect CYP3A4, the main pathway clearing 50-70% of atorvastatin. Older Hep C treatments like interferon/ribavirin rarely interacted.[1]
Alternatives for Patients on Both?
| Hep C Regimen | Preferred Statin Alternative | Max Atorvastatin Dose |
|---------------|------------------------------|-----------------------|
| Mavyret | Pravastatin (40 mg), rosuvastatin (10 mg) | 20 mg |
| Epclusa | Rosuvastatin (10 mg) | 20 mg |
| Zepatier | Fluvastatin, pravastatin | Avoid |
| Harvoni | Pitavastatin | 20 mg |
Patients with Hep C and high cardiovascular risk may need lipid specialist input.[2][3]
[1]: FDA Drug Interactions Table for Atorvastatin
[2]: Hepatitis C Guidance 2023 - AASLD/IDSA
[3]: Liverpool HEP Interactions Checker